| Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy AM Chinnaiyan, U Prasad, S Shankar, DA Hamstra, M Shanaiah, ... Proceedings of the National Academy of Sciences 97 (4), 1754-1759, 2000 | 676 | 2000 |
| Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image … N Mariados, J Sylvester, D Shah, L Karsh, R Hudes, D Beyer, S Kurtzman, ... International Journal of Radiation Oncology* Biology* Physics 92 (5), 971-977, 2015 | 411 | 2015 |
| Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy RD Tendulkar, S Agrawal, T Gao, JA Efstathiou, TM Pisansky, ... Journal of Clinical Oncology 34 (30), 3648-3654, 2016 | 396 | 2016 |
| Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology DA Hamstra, A Rehemtulla, BD Ross Journal of clinical oncology 25 (26), 4104-4109, 2007 | 396 | 2007 |
| Continued benefit to rectal separation for prostate radiation therapy: final results of a phase III trial DA Hamstra, N Mariados, J Sylvester, D Shah, L Karsh, R Hudes, D Beyer, ... International Journal of Radiation Oncology* Biology* Physics 97 (5), 976-985, 2017 | 383 | 2017 |
| Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma DA Hamstra, TL Chenevert, BA Moffat, TD Johnson, CR Meyer, ... Proceedings of the National Academy of Sciences 102 (46), 16759-16764, 2005 | 373 | 2005 |
| Prediction of erectile function following treatment for prostate cancer M Alemozaffar, MM Regan, MR Cooperberg, JT Wei, JM Michalski, ... Jama 306 (11), 1205-1214, 2011 | 364 | 2011 |
| Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trial JM Michalski, J Moughan, J Purdy, W Bosch, DW Bruner, JP Bahary, ... JAMA oncology 4 (6), e180039-e180039, 2018 | 360 | 2018 |
| Noninvasive real-time imaging of apoptosis B Laxman, DE Hall, MS Bhojani, DA Hamstra, TL Chenevert, BD Ross, ... Proceedings of the National Academy of Sciences 99 (26), 16551-16555, 2002 | 359 | 2002 |
| Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival DA Hamstra, CJ Galbán, CR Meyer, TD Johnson, PC Sundgren, C Tsien, ... Journal of clinical oncology 26 (20), 3387-3394, 2008 | 340 | 2008 |
| Minimally important difference for the expanded prostate cancer index composite short form TA Skolarus, RL Dunn, MG Sanda, P Chang, TK Greenfield, MS Litwin, ... Urology 85 (1), 101-106, 2015 | 311 | 2015 |
| Defining a standard set of patient-centered outcomes for men with localized prostate cancer NE Martin, L Massey, C Stowell, C Bangma, A Briganti, A Bill-Axelson, ... European urology 67 (3), 460-467, 2015 | 263 | 2015 |
| Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma C Tsien, CJ Galbán, TL Chenevert, TD Johnson, DA Hamstra, ... Journal of Clinical Oncology 28 (13), 2293-2299, 2010 | 251 | 2010 |
| The parametric response map is an imaging biomarker for early cancer treatment outcome CJ Galbán, TL Chenevert, CR Meyer, C Tsien, TS Lawrence, DA Hamstra, ... Nature medicine 15 (5), 572-576, 2009 | 250 | 2009 |
| Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma SJ Hughes, Y Nambu, OS Soldes, D Hamstra, A Rehemtulla, ... Cancer research 57 (24), 5571-5578, 1997 | 184 | 1997 |
| A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of … CJ Galbán, SK Mukherji, TL Chenevert, CR Meyer, DA Hamstra, ... Translational oncology 2 (3), 184-190, 2009 | 172 | 2009 |
| Absorbable hydrogel spacer use in prostate radiotherapy: a comprehensive review of phase 3 clinical trial published data LI Karsh, ET Gross, CM Pieczonka, PJ Aliotta, CJ Skomra, LE Ponsky, ... Urology 115, 39-44, 2018 | 122 | 2018 |
| Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase DA Hamstra, DJ Rice, S Fahmy, BD Ross, A Rehemtulla Human gene therapy 10 (12), 1993-2003, 1999 | 119 | 1999 |
| Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas. Y Nambu, SJ Hughes, A Rehemtulla, D Hamstra, MB Orringer, DG Beer The Journal of clinical investigation 101 (5), 1102-1110, 1998 | 119 | 1998 |
| Carboxy-terminal conversion of profibrillin to fibrillin at a basic site by PACE/furin-like activity required for incorporation in the matrix M Raghunath, EA Putnam, T Ritty, D Hamstra, ES Park, ... Journal of cell science 112 (7), 1093-1100, 1999 | 118 | 1999 |
Howard SandlerCedars-Sinai Medical CenterВерификована је имејл адреса на cshs.org